Literature DB >> 16837062

Niacin skin flushing in schizophrenic and depressed patients and healthy controls.

Linda Bosveld-van Haandel1, Rikus Knegtering, Herman Kluiter, Robert J van den Bosch.   

Abstract

This study compares the skin reactions to the niacin flushing test of 16 schizophrenic patients with those of 17 depressed patients and 16 healthy controls. Methyl nicotinate (niacin) in a concentration of 0.1 M was applied to the forearm for 5 min. Significant differences could be observed between the group of schizophrenic patients (less flushing) in comparison to the other groups. There were no statistical differences in niacin flushing between patients with depression and healthy controls. Gender, age and the use of antipsychotic agents did not appear to be confounders. The differences in flushing within the group of schizophrenic patients were striking, however. Most patients showed little or no flushing, but some patients reacted strongly. Although the three groups could be differentiated by the niacin flushing test, to develop a reliable clinical application of this test, further research is necessary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837062     DOI: 10.1016/j.psychres.2005.10.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia.

Authors:  Yin-Ju Lien; Sih-Syuan Huang; Chih-Min Liu; Hai-Gwo Hwu; Stephen V Faraone; Ming T Tsuang; Wei J Chen
Journal:  Schizophr Bull       Date:  2011-06-07       Impact factor: 9.306

2.  Niacin sensitivity and the arachidonic acid pathway in schizophrenia.

Authors:  Erik Messamore; William F Hoffman; Jeffrey K Yao
Journal:  Schizophr Res       Date:  2010-04-24       Impact factor: 4.939

Review 3.  The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders.

Authors:  E Schwarz; S Bahn
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

4.  Potential metabolite markers of schizophrenia.

Authors:  J Yang; T Chen; L Sun; Z Zhao; X Qi; K Zhou; Y Cao; X Wang; Y Qiu; M Su; A Zhao; P Wang; P Yang; J Wu; G Feng; L He; W Jia; C Wan
Journal:  Mol Psychiatry       Date:  2011-10-25       Impact factor: 15.992

Review 5.  Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia.

Authors:  Sabrina H Ansarey
Journal:  Front Psychiatry       Date:  2021-11-30       Impact factor: 4.157

6.  Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading.

Authors:  Shu-Sen Chang; Chih-Min Liu; Sheng-Hsiang Lin; Hai-Gwo Hwu; Tzung J Hwang; Shi K Liu; Ming H Hsieh; Shi-Chin Guo; Wei J Chen
Journal:  Schizophr Bull       Date:  2008-01-18       Impact factor: 9.306

7.  Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'.

Authors:  Brian M Ross; Martin Katzman
Journal:  BMC Res Notes       Date:  2008-09-24

8.  Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population.

Authors:  Liya Sun; Xuhan Yang; Jie Jiang; Xiaowen Hu; Ying Qing; Dandan Wang; Tianqi Yang; Chao Yang; Juan Zhang; Ping Yang; Peng Wang; Changqun Cai; Jijun Wang; Lin He; Chunling Wan
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.